Review of secukinumab‐induced adverse events of special interest and its potential pathogenesis
Author:
Affiliation:
1. Institute of Dermatology Guangzhou Medical University Guangzhou P.R. China
2. Department of Dermatology Guangzhou Institute of Dermatology Guangzhou P.R. China
Publisher
Hindawi Limited
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15599
Reference99 articles.
1. Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety
2. Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review
3. Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticaria
4. Safety of secukinumab in the treatment of psoriasis
5. Occurrence of Henoch–Schönlein purpura in a patient treated with secukinumab
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serious adverse events associated with systemic treatments for psoriasis: a network meta-analysis of observational studies and randomized controlled trials;Cochrane Database of Systematic Reviews;2024-04-18
2. The unexpected guest: Cytotoxic, pseudolymphoma‐like reaction at the site of primary cutaneous follicle centre B‐cell lymphoma in a patient receiving secukinumab for psoriasis;Journal of the European Academy of Dermatology and Venereology;2024-02-09
3. IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment;International Immunopharmacology;2023-10
4. Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real‐world practice;Experimental Dermatology;2023-07-20
5. Lupus Nephritis: New and Emerging Biologic and Targeted Therapies;BioDrugs;2023-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3